BRD4 gene amplification has been identified in ovarian cancer (~18–19%) according to The Cancer Genome Atlas (TCGA) analysis while increased BRD4 mRNA levels have been identified in 9% of ovarian cancers [8]. Here, BRD4 is linked to ovarian carcinoma.